Nordic NanoVector's Unattributed VC Round

Nordic NanoVector raised a round of funding on September 27, 2013. Investors include HealthCap Venture Capital.

Nordic Nanovector is focusing on the development and commercialization of novel targeted therapeutics for haematological cancers. The Company's lead clinical-stage product opportunity is Betalutin, th…

Articles about Nordic NanoVector's Unattributed VC Round: